109 related articles for article (PubMed ID: 27018445)
1. Damnacanthal and its nanoformulation exhibit anti-cancer activity via cyclin D1 down-regulation.
Sukamporn P; Rojanapanthu P; Silva G; Zhang X; Gritsanapan W; Baek SJ
Life Sci; 2016 May; 152():60-6. PubMed ID: 27018445
[TBL] [Abstract][Full Text] [Related]
2. Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells.
Nualsanit T; Rojanapanthu P; Gritsanapan W; Lee SH; Lawson D; Baek SJ
J Nutr Biochem; 2012 Aug; 23(8):915-23. PubMed ID: 21852088
[TBL] [Abstract][Full Text] [Related]
3. Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy.
Li R; Li H; Lan J; Yang D; Lin X; Xu H; Han B; Yang M; Su B; Liu F; Jiang W
Phytomedicine; 2022 Jun; 100():154084. PubMed ID: 35421676
[TBL] [Abstract][Full Text] [Related]
4. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation.
Cheng YH; Li LA; Lin P; Cheng LC; Hung CH; Chang NW; Lin C
Toxicol Appl Pharmacol; 2012 Sep; 263(3):360-7. PubMed ID: 22820424
[TBL] [Abstract][Full Text] [Related]
5. Vitex rotundifolia Fruit Suppresses the Proliferation of Human Colorectal Cancer Cells through Down-regulation of Cyclin D1 and CDK4 via Proteasomal-Dependent Degradation and Transcriptional Inhibition.
Song HM; Park GH; Park SB; Kim HS; Son HJ; Um Y; Jeong JB
Am J Chin Med; 2018; 46(1):191-207. PubMed ID: 29298515
[TBL] [Abstract][Full Text] [Related]
6. The noni anthraquinone damnacanthal is a multi-kinase inhibitor with potent anti-angiogenic effects.
García-Vilas JA; Pino-Ángeles A; Martínez-Poveda B; Quesada AR; Medina MÁ
Cancer Lett; 2017 Jan; 385():1-11. PubMed ID: 27816491
[TBL] [Abstract][Full Text] [Related]
7. The antinociceptive and anti-inflammatory action of the CHCl3-soluble phase and its main active component, damnacanthal, isolated from the root of Morinda citrifolia.
Okusada K; Nakamoto K; Nishida M; Fujita-Hamabe W; Kamiya K; Mizushina Y; Satake T; Tokuyama S
Biol Pharm Bull; 2011; 34(1):103-7. PubMed ID: 21212526
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Potential of Damnacanthal and Nordamnacanthal from
Latifah SY; Gopalsamy B; Abdul Rahim R; Manaf Ali A; Haji Lajis N
Molecules; 2021 Mar; 26(6):. PubMed ID: 33808969
[TBL] [Abstract][Full Text] [Related]
9. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
10. Damnacanthal inhibits the NF-κB/RIP-2/caspase-1 signal pathway by inhibiting p56lck tyrosine kinase.
Kim MH; Jeong HJ
Immunopharmacol Immunotoxicol; 2014 Oct; 36(5):355-63. PubMed ID: 25139491
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone I induces cyclin D1 proteasomal degradation in an ERK1/2 dependent way in human colorectal cancer cells.
Kim MK; Park GH; Eo HJ; Song HM; Lee JW; Kwon MJ; Koo JS; Jeong JB
Fitoterapia; 2015 Mar; 101():162-8. PubMed ID: 25615593
[TBL] [Abstract][Full Text] [Related]
12. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
13. Damnacanthal inhibits IgE receptor-mediated activation of mast cells.
Garcia-Vilas JA; Medina MA; Melo FR; Pejler G; Garcia-Faroldi G
Mol Immunol; 2015 May; 65(1):86-93. PubMed ID: 25656801
[TBL] [Abstract][Full Text] [Related]
14. Effects of Damnacanthal and Nordamnacanthal on Proliferation, Apoptosis, and Migration of Oral Squamous Cell Carcinoma Cells.
Shaghayegh G; Alabsi AM; Ali-Saeed R; Ali AM; Vincent-Chong VK; Ismail NH; Choon YF; Zain RB
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3333-3341. PubMed ID: 29286228
[TBL] [Abstract][Full Text] [Related]
15. Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression.
Matsuzaki Y; Koyama M; Hitomi T; Yokota T; Kawanaka M; Nishikawa A; Germain D; Sakai T
Oncol Rep; 2008 Mar; 19(3):721-7. PubMed ID: 18288407
[TBL] [Abstract][Full Text] [Related]
16. Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells.
García-Vilas JA; Quesada AR; Medina MA
Sci Rep; 2015 Jan; 5():8021. PubMed ID: 25620570
[TBL] [Abstract][Full Text] [Related]
17. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways.
Lin FL; Hsu JL; Chou CH; Wu WJ; Chang CI; Liu HJ
Eur J Pharmacol; 2011 Jan; 650(1):120-9. PubMed ID: 20951126
[TBL] [Abstract][Full Text] [Related]
18. Damnacanthal-induced anti-inflammation is associated with inhibition of NF-κB activity.
Nualsanit T; Rojanapanthu P; Gritsanapan W; Kwankitpraniti T; Min KW; Baek SJ
Inflamm Allergy Drug Targets; 2011 Dec; 10(6):455-63. PubMed ID: 21999179
[TBL] [Abstract][Full Text] [Related]
19. Development of biodegradable sustained-release damnacanthal nanocapsules for potential application in in-vitro breast cancer studies.
Mohd MR; Ariff TM; Mohamad N; Abdul Latif AZ; Wan Nik WMN; Mohamed A; Suffian IFM
Pak J Pharm Sci; 2019 Sep; 32(5):2155-2162. PubMed ID: 31813882
[TBL] [Abstract][Full Text] [Related]
20. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
